Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI

Recruiting now · Phase 1

Conditions studied: Spinal Cord Injuries

In brief

This trial will study the safety and efficacy of intrathecal injection of cultured autologous adult adipose derived mesenchymal stem cells versus cultured allogeneic adult umbilical-cord derived mesenchymal stem cells for the treatment of spinal cord injury

Key facts

Study ID

NCT05018793

Run by

The Foundation for Orthopaedics and Regenerative Medicine

People needed

15

Starts

2024-12-01

Expected to finish

2028-12-01

Last updated by the study team

2025-04-17

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Spinal Cord Injury
• Understanding and willingness to sign a written informed consent document

You may not qualify if…

• Active infection
• Active cancer
• Chronic multisystem organ failure
• Pregnancy
• Anticoagulation medicine use
• Clinically significant Abnormalities on pre-treatment laboratory evaluation
• Medical condition that would (based on the opinion of the investigator) compromise patient's safety.
• Previous organ transplant
• Hypersensitivity to sulfur
• Continued drug abuse
• Pre-menopausal women not using contraception

Where it is running

• Medical Surgical Associates Center — St John's, Antigua and Barbuda (enrolling)
• Athens Beverly Hills Medical Group — Glyfada, Athens, Greece (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.